```json
{
"content": [
{
"type": "paragraph",
"content": "Application segmentation in the Cardiac RF Ablation Catheter market is driven by clinical demand, with Atrial Fibrillation (AFib) and Ventricular Arrhythmias as key subcategories. AFib, the most prevalent arrhythmia, accounts for over 60% of global ablation procedures, making it the largest application segment. Its high incidence in aging populations and rising preference for minimally invasive therapies underscore its dominance. Ventricular Arrhythmias, while less common, require specialized catheters for complex ablations, particularly in post-myocardial infarction patients. This niche segment grows steadily due to advancements in mapping technologies. Together, these applications define the Cardiac RF Ablation Catheter segmentation, with AFib’s market share projected to remain above 65% through 2030."
},
{
"type": "paragraph",
"content": "Types segmentation is categorized into Non-Steerable and Steerable catheters. Non-Steerable variants, comprising ~30% of the market, are simpler devices used for basic ablations, often in resource-constrained settings. Their limited maneuverability restricts use to straightforward procedures. Steerable catheters, accounting for 70% of the market, dominate due to superior control and precision. Innovations like adjustable tip curvature and real-time feedback systems enhance their adoption in complex cases like AFib. This market taxonomy reflects a shift toward advanced, procedure-specific catheters. Steerable variants also benefit from integration with 3D mapping systems, driving growth in high-income regions. Non-Steerable catheters retain relevance in low-acuity cases but face declining market share as procedural complexity rises."
}
],
"chartData": {
"segments": [
{ "name": "Atrial Fibrillation", "value": 65 },
{ "name": "Ventricular Arrhythmias", "value": 35 }
]
}
}
```
